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Abstract
The endoplasmic reticulum (ER) is a highly dynamic organelle in eukaryotic
cells. It is deputed to lipid and protein biosynthesis, calcium storage, and the
detoxification of various exogenous and endogenous harmful compounds. ER
activity and size must be adapted rapidly to environmental and developmental
conditions or biosynthetic demand. This is achieved on induction of thoroughly
studied transcriptional/translational programs defined as “unfolded protein
responses” that increase the ER volume and the expression of ER-resident
proteins regulating the numerous ER functions. Less understood are the
lysosomal catabolic processes that maintain ER size at steady state, that
prevent excessive ER expansion during ER stresses, or that ensure return to
physiologic ER size during recovery from ER stresses. These catabolic
processes may also be activated to remove ER subdomains where
proteasome-resistant misfolded proteins or damaged lipids have been
segregated. Insights into these catabolic mechanisms have only recently
emerged with the identification of so-called ER-phagy receptors, which label
specific ER subdomains for selective lysosomal delivery for clearance. Here, in
eight chapters and one addendum, we comment on recent advances in ER
turnover pathways induced by ER stress, nutrient deprivation, misfolded
proteins, and live bacteria. We highlight the role of yeast (Atg39 and Atg40) and
mammalian (FAM134B, SEC62, RTN3, and CCPG1) ER-phagy receptors and
of autophagy genes in selective and non-selective catabolic processes that
regulate cellular proteostasis by controlling ER size, turnover, and function.
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The history behind regulated endoplasmic reticulum 
turnover
The volume (and the activity) of the endoplasmic reticulum (ER) 
can be expanded on demand. Activation of quiescent B cells 
into antibody-producing plasma cells is a textbook example of 
the daunting expansion of this biosynthetic organelle to accom-
modate and assist the maturation of a flood of cargo entering 
the secretory pathway (in this specific case, thousands of immu-
noglobulin chains produced per second)1. In general terms, ER 
expansion is one of the many cellular responses to ER stresses, 
which collectively are defined as unfolded protein responses 
(UPR). Logically, recovery of pre-stress homeostasis upon 
ER stress resolution or cessation of drug (e.g. phenobarbital) 
treatments requires dismantling of the excess ER and degrada-
tion of the ER chaperones produced during the stress phase2. It 
is in these contexts that first indications of catabolic control of 
ER size emerged3–5. However, hints of lysosomal-regulated 
ER turnover can be found in earlier literature (for example, in 6). 
Selective ER turnover is a constitutive process that maintains 
ER size in Eukarya. It can be enhanced or induced on micro-
tubule de-polymerization7 and, as described below, during ER 
stress, during recovery from acute ER stress, on ER overload 
with membrane or proteasome-resistant misfolded proteins, 
under nutrient deprivation, or on pathogen attack. It relies on 
intricate mechanisms that we are just starting to understand.
Yeast flavors of ER-phagy
Chapter one: the origin of a name. ER-phagy as ER stress-
induced microautophagy of the ER
The term ER-phagy is a contraction of the words “ER” and 
“macroautophagy”. It was coined by the group of Peter Walter 
to define the process of selective ER delivery (not of selec-
tive ER clearance) in the vacuole of yeast cells exposed to per-
turbation of the redox homeostasis to induce a UPR8. Initially, 
ER-phagy was described as a conventional macroautophagic 
pathway with autophagy genes alleviating cell growth defects 
under ER stress conditions and regulating the engulfment of 
ER fragments within double-membrane autophagosomes that 
eventually fuse with vacuoles to clear their content8,9. None of 
these original findings survived the test of time. In fact, further 
analyses by the same group revealed that neither autophagy 
genes nor autophagosomes are actually involved in the vacuolar 
delivery of excess ER upon perturbation of redox homeostasis 
or play a role in the survival of yeast cells challenged with the 
reducing agent dithiothreitol (DTT). Moreover, it turns out that 
ER delivery to the vacuole under these experimental conditions 
does not result in ER clearance10 (Table 1). Rather, on chemical 
UPR induction, excess ER membranes are delivered within 
the vacuole by poorly understood micropinocytosis events. 
Importantly, because DTT inactivates vacuolar activity, the ER 
delivered into the vacuole under these experimental conditions 
accumulates in the vacuolar lumen as ER whorls10. The path-
ways and the yeast genes regulating ER fragmentation, selec-
tive delivery of ER whorls within vacuoles (is it controlled 
by ER-phagy receptors?), and capture of ER by microau-
tophagic invagination of the vacuolar membrane remain to be 
identified.
Chapter two: membrane protein-induced macroautophagy 
of the ER
Overexpression of integral membrane proteins is yet another 
manner to activate/enhance delivery of ER to the yeast 
vacuole11,12. This process is highly selective because endog-
enous markers of the ER membrane (Sec61 and Hmg1) but 
not intrinsic or peripheral proteins of ER exit sites (Sec12 and 
Sec13) or the luminal ER protein Kar2p are delivered to the 
vacuole with the exogenous integral protein(s) to be cleared 
from cells11. Membrane protein-induced delivery of ER material 
to the yeast vacuole is under the control of Ypt1 (the orthologue 
of mammalian RAB1) to generate ER-to-autophagy membrane 
structures, of Ypt51 (Vps2) to promote fusion of ER membrane 
proteins-containing structures with the vacuole, and of select 
macroautophagy gene products (Atg1, Atg2, Atg8, Atg9, and 
Atg11 but not Atg17, Atg18, Atg19, Atg32, and Atg3611; for 
a description of the function of the various autophagy gene 
products mentioned in this commentary, please refer to 13,14) 
(Table 1). The role of Atg39 and Atg40 as ER-phagy receptors 
in nutrient deprivation-induced yeast ER-phagy was published 
subsequently (chapter three in this commentary and 15). To our 
knowledge, a possible involvement of Atg39 or Atg40 (or both) 
in membrane protein-induced selective macroautophagy remains 
to be investigated.
Chapter three: nutrient deprivation-induced, receptor (Atg39 
and Atg40)-mediated macroautophagy of the ER (and of 
the nuclear envelope)
Nutrient deprivation and rapamycin are conventional activators 
of macroautophagy16. Like cell exposure to DTT10, these 
experimental conditions enhance the delivery of ER frag-
ments within the yeast vacuole. However, as crucial differences 
(compare with chapter one), vacuolar delivery eventually 
results in ER clearance15,17 and relies on macroautophagy-like 
Table 1. Yeast ER-phagy types and their requirements.
ER-phagy type (yeast) Receptor Gene products required Gene products dispensable
Dithiothreitol-induced microER-phagy8–10 Unknown Unknown Atg1, Atg7, Atg8, Atg16, Ego1, Ego3, 
Vtc4, Nvj1, Pep4, Vps4, Vps23
Membrane protein-induced macroER-
phagy11
Unknown Atg1, Atg2, Atg8, Atg9, 
Atg11, Ypt1, Ypt51
Atg17, Atg18, Atg19, Atg32, Atg36
Nutrient deprivation-induced/rapamycin-
induced ER-phagy15
Atg39 or 
Atg40
Atg1, Atg8, Atg11, 
Atg17, Ypt7, Pep4
Unknown
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programs, where receptor-mediated engulfment of ER frag-
ments into double-membrane autophagosomes that eventually 
fuse with lysosomes does indeed occur15,17,18. Atg39 spans the 
perinuclear ER membrane and decorates it for capture by 
autophagosomes and destruction. Instead, Atg40 is in the 
peripheral ER membrane, where it co-localizes with Rtn1, a 
marker of ER tubules and sheet edges, but not with the ER sheet 
marker Sec63 and regulates the turnover of highly curved ER 
subdomains (Figure 1). Atg39 and Atg40 contain an Atg8- 
interacting motif (AIM) that bridges the ER membrane with the 
phagophore membrane via Atg8 association. Moreover, Atg40 
(and possibly Atg39) contains an Atg11-binding region (11BR, 
Figure 1) and harbors two transmembrane domains that have 
some similarities with reticulon domains displayed by some 
mammalian ER-phagy receptors (15, see below). These 
domains supposedly curve the ER membrane to facilitate the 
ER fragmentation required for engulfment by autophagosomes. 
So far, it has been established that nutrient deprivation-induced, 
Atg39- and Atg40-mediated macroautophagy of the yeast 
nuclear envelope and ER requires Atg1 (ULK1 in mammals), 
Atg8 (LC3), Atg11 and Atg17, Ypt7 (RAB7, a small 
GTPase required for autophagosome-vacuole fusion), and Pep4 
(a vacuolar peptidase)15 (Table 1).
Mammalian flavors of ER-phagy
Chapter four: nutrient deprivation-induced, receptor 
(FAM134B or RTN3)-mediated macroautophagy of the ER
As in yeast cells, starvation activates receptor-mediated engulf-
ment of mammalian ER fragments into double-membrane 
autophagosomes that eventually fuse with lysosomes to clear 
their cargo19,20. The reticulon family members FAM134B and 
RTN3 reside to the edges of ER sheets and ER tubuli, respectively 
(Figure 1). FAM134B was identified in a yeast two-hybrid 
screen as a LC3/GABARAP interactor19. RTN3 was found to 
re-localize from ER tubuli to LC3-decorated structures on cell 
starvation20. Upon oligomerization, FAM134B and RTN3 frag-
ment ER sheets and tubuli, respectively, and mediate the capture 
of these ER subdomains by autophagosomes via their LC3- 
interacting regions (LIRs). As such, different ER-phagy 
receptors regulate the turnover of distinct populations of ER-
resident proteins, according to the subcompartmental distribution 
of the latter in sheets (for example, CLIMP63 and RTN4B) or in 
tubuli (RTN1, RTN3, REEP5, and CNX). Since inactivation of 
ER-phagy receptors causes ER expansion, ER turnover is a 
constitutive process that also determines ER size at steady state. 
So far, it has been established that nutrient deprivation- 
induced, FAM134B- and RTN3-mediated ER-phagy requires 
BCN1, ATG5, ATG7, LC3, and FIP20019,20 (Table 2).
Chapter five: receptor (SEC62)-mediated clearance of 
excess ER on resolution of acute ER stresses (recovER-
phagy)
Pathologic (for example, expression of mutant polypeptides) 
or physiologic (for example, B- to plasma-cell differentiation) 
biosynthetic challenges may induce ER stresses that increase the 
ER volume to almost entirely occupy the space delimited by the 
plasma membrane (http://www.drjastrow.de/WAI/EM/EMRERE.
html). This can be recapitulated by challenging cells with 
chemical compounds or by therapeutic interventions that perturb 
ER homeostasis21. Alleviation of the stress obtained on inter-
ruption of the challenge allows cells to re-establish pre-stress 
homeostatic conditions by lysosomal clearance of the excess ER 
membranes and proteins produced during the stress phase2–5. This 
catabolic process, defined as recovER-phagy (for ER-phagy-
mediated recovery from ER stresses2), is characterized by selec-
tive clearance of ER subdomains displaying the LC3-binding 
protein and (recov)ER-phagy receptor SEC62 at the limiting 
membrane2 (Figure 1). SEC62 plays a well-characterized role 
as a component of the protein import machinery into the ER22. 
Bioinformatics analyses revealed the presence of a LIR in the 
Figure 1. Yeast and mammalian ER-phagy receptors. The figure shows the topology, orientation, and subcompartmental localization of 
the two yeast ER-phagy receptors Atg39 and Atg40 and of the four mammalian ER-phagy receptors RTN3, CCPG1, FAM134B, and SEC62. 
Numbers indicate amino acid residues and refer to the human version of the proteins for the mammalian ER-phagy receptors. 11BR, Atg11-
binding region; AIM, Atg8-interacting motif; ER, endoplasmic reticulum; FIR, FIP200-interacting region; LIR, LC3-interacting region; RHD, 
reticulon-homology domain; TMD, transmembrane domain.
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Table 2. Mammalian ER-phagy types and their requirements.
ER-phagy type (mammalian) Receptor Gene products required Gene products 
dispensable
Nutrient deprivation-induced 
ER-phagy19,20
FAM134B BCN1, FIP200, ATG5, LC3 RTN3
RTN3 FIP200, ATG5, ATG7, LC3 FAM134B
Nutrient deprivation-induced/
ER stress-induced ER-phagy23
CCPG1 FIP200, ATG5, LC3 Unknown
RecovER-phagy2 SEC62 ATG5, ATG7, LC3 Unknown
Microbial-induced ER-phagy24 Unknown BCN1, FIP200, ATG7, 
ATG14, ATG16L1 
FAM134B
cytosolic C-terminus of SEC62, which is conserved in higher 
Eukarya but not in the yeast orthologue. LC3 binding to SEC62 
has been mapped by docking and molecular dynamics simu-
lations and by solution nuclear magnetic resonance spectros-
copy. It has been confirmed by surface plasmon resonance and 
peptide array and eventually in the living cell, where it proved 
to be required for the delivery of ER fragments within LAMP1- 
positive degradative organelles2. Proteomic analyses revealed 
that the ER subdomains cleared by recovER-phagy do contain 
several ER-resident molecular chaperones and enzymes (for 
example, all members of the protein disulfide isomerase super-
family with the relevant exception of ERp44, which resides not in 
the ER but in the intermediate compartment25) but are devoid of 
other ER-resident proteins such as most ERAD regulators2. This 
reveals a spatial separation of ER functions in ER subdomains. 
So far, it has been established that SEC62-mediated recovER- 
phagy requires ATG5, ATG7, and LC3 (Table 2).
Chapter six: ER stress-induced receptor (CCPG1)-
mediated macroautophagy of the ER
CCPG1 is the new entry in the ER-phagy receptors clan. 
It has been identified as an ER stress-induced interactor of 
GABARAP and LC323,26. It is a single-pass, type II ER protein 
that associates directly with FIP200 and indirectly with other 
components of the ULK complex involved in autophagosome 
biogenesis (that is, ULK1, ATG13, and ATG101)23 (Figure 1). 
Ectopic expression of CCPG1 reduces the size of the periph-
eral ER and the cellular content of the peripheral/tubular ER 
protein RTN3. Likewise, induction of endogenous CCPG1 
in cells challenged with the chemical ER stress inducer DTT 
activates lysosomal depletion of peripheral ER. DTT induction 
of yeast ER-phagy results in microautophagy-like vacuolar 
capture of the ER, which does not require intervention of 
autophagy gene products and does not lead to ER degrada-
tion (Chapter one10). Thus, the mechanism of ER size control 
in cells experiencing chemically induced ER stresses is poorly 
conserved, if at all. Of note, FAM134B deficiency is linked to 
human sensory neuropathy19, whereas studies in mice reveal that 
CCPG1 deficiency causes injury of exocrine pancreas cells and 
of chief cells of the gastric epithelium23. These differences reveal 
poorly understood tissue-specific functions of the two ER-phagy 
receptors. CCPG1-mediated ER-phagy requires ATG5 and 
FIP200 (Table 2). 
Chapter seven: misfolded protein-induced macroautophagy 
of the ER (ER quality control autophagy)
Most misfolded polypeptides produced in the ER are translo-
cated across the ER membrane and are degraded by cytosolic 
26S proteasomes27. However, the polymerogenic E342K (ATZ) 
variant of the secretory protein alpha1 antitrypsin28–31, the E90K 
mutant of the gonadotropin-releasing hormone receptor 
(GnRHR)32, aggregated β subunits of thyrotrophic hormone33, 
procollagen34,35, and dysferlin36 are a few paradigmatic examples 
of proteasome-resistant proteins generated in the ER and 
degraded, at least in part, by the lysosomal system. For ATZ, the 
involvement of classic autophagy regulators such as ATG5, 
ATG7, and LC3 has been shown31. However, for this and other 
proteasome-resistant misfolded polypeptides such as GnRHR 
and β subunits of thyrotrophic hormone, the intervention of 
classic (mTOR-dependent) macroautophagy pathways in clear-
ance is questionable. In fact, macroautophagy inducers such 
as rapamycin and starvation do not enhance their lysosomal 
disposal30,32,37,38, which seems to actually require vesicular 
traffic from the ER to lysosomal degradative compartments33,39. 
In these cases, the autophagy genes involved in these catabolic 
processes might intervene in an ill-defined, unconventional 
manner. Even if/when conventional macroautophagy deter-
mines the clearance of proteasome-resistant misfolded proteins 
generated in the ER lumen, it remains unclear whether these are 
dislocated across the ER membrane and subsequently are cap-
tured by autophagosomes or whether autophagosomes capture 
ER fragments containing aberrant protein aggregates to then fuse 
to lysosomes31. In the latter case, it remains to be established 
how the autophagic machinery operating in the cytosol can 
detect the accumulation in the ER lumen of proteasome- 
resistant species to be removed from cells (see “Final remarks”). 
All in all, the involvement of peculiar pathways (autophagy-
like or vesicular transport or both), of ER-resident sensors that 
transmit the information from the ER lumen into the cytosol to 
activate autophagy, and of ER-phagy receptors to promote the 
catabolic process that removes the ER subdomain from cells 
seems to be an educated guess.
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Chapter eight: microbial-induced ER-phagy
Cyclic-di-adenosine monophosphate is a signature of live Gram-
positive bacteria, which is detected by phagocytes to trigger a 
protective ER stress response consisting of ER expansion and 
chaperone gene upregulation. Subsequently, ER stress-induced 
PERK phosphorylation correlates with mTORC1 inactivation, 
thus inducing macroautophagy, which is instrumental for cell 
survival24. Isolation of autophagosomes from cells challenged 
with live bacteria revealed the presence of several ER mark-
ers and the absence of markers of ERGIC, Golgi or lysosome, 
showing that live bacteria induce selective ER-phagy. A role for 
FAM134B as a receptor for microbial-induced ER-phagy has 
been excluded. The involvement of other known ER-phagy 
receptors has not been tested24. So far, it has been established 
that microbial-induced ER-phagy requires ATG7, ATG14, 
ATG16L1, BCN1, and FIP200 (Table 2).
Promiscuous autophagic receptors in ER-phagy, an 
addendum: the case of p62 and BNIP3
As originally reported for other drugs3–5, withdrawal of hepatic 
mitogens activates the removal of excess ER from liver cells, 
which is ensured by macroautophagic processes. In these in vivo 
experiments, ER turnover required ATG5 and the general 
autophagy receptor Sequestosome1/p6240. In contrast to conven-
tional ER-phagy receptors, which are located in the ER membrane 
(Figure 1), p62 is a cytosolic protein that links ubiquitylated 
proteins to be degraded to the autophagic machinery via LC3 
interaction. It is therefore likely that p62 regulates the clear-
ance of ER regions displaying heavily ubiquitylated proteins at 
the cytosolic face of the membrane. A second intriguing case of 
promiscuous receptors involved in ER turnover is that of BNIP3, 
which is anchored primarily in the outer mitochondrial mem-
brane via a C-terminal transmembrane domain41. The BNIP3 
homologue NIX/BNIP3L preferentially binds GABARAP42 
and regulates the removal of damaged mitochondria43. BNIP3 
selectively removes damaged mitochondria on association with 
LC3B44. The finding that a subfraction of cellular BNIP3 is 
also found in the ER membrane led to the postulation that this 
protein could play a role as an ER-phagy receptor44. This was 
experimentally demonstrated only on ectopic expression of a 
BNIP3 version modified for preferential delivery into the ER 
membrane44.
Final remarks
Autophagy was once considered a rather unselective pathway 
to deliver faulty material to lysosomes for clearance. Recent 
studies reveal the specificity and sophistication of autophagic 
programs and of programs relying on unconventional roles 
of autophagy genes45. Organelles such as mitochondria, 
peroxisomes, nucleus, and ER can selectively be delivered to 
the lysosomal pathway for destruction if and when they display 
receptors at the surface that engage this intricate catabolic 
machinery46. These receptors are constitutively active, for 
example, to control the size of the ER at steady state or in rest-
ing cells. They can be activated on demand to recover pre- 
stress ER size and content or in response to accumulation in 
specific ER subdomains of misfolded polypeptides that can-
not be handled by the ubiquitin proteasome system. The study of 
ER-phagy actually reveals that not only organelles but also 
specific (functional) subdomains of an organelle, with their 
content, can be selected for destruction. The field is young 
and relies mostly on studies performed in cells exposed to 
exogenous stimuli such as nutrient deprivation or chemical 
stress that activate selective and non-selective ER-phagy and 
have uncontrolled pleiotropic consequences on many unrelated 
pathways47. Intrinsic signals (that is, signals originating from 
the membrane or the lumen of confined ER subcompartments 
such as accumulation of proteasome-resistant polypeptides) 
are predicted to activate highly specific, receptor-controlled 
pathways relying on different autophagy, autophagy-like, or 
autophagy-independent lysosomal pathways. We also pre-
dict that studies on ER turnover will lead to the identification of 
ER sensors that, much like ER stress sensors, signal 
accumulation of proteasome-resistant misfolded proteins or 
other stressful situations that must be resolved by ER clear-
ance. Analysis of the available literature already shows that 
ER-phagy comprises a series of mechanistically distinct proc-
esses that regulate the delivery of ER fragments or their luminal 
content (or both) within vacuoles/lysosomes. It is proposed, but 
in most cases not yet experimentally demonstrated, that these 
catabolic processes regulate ER turnover, ER size, and clear-
ance of ER subdomains containing proteins and lipids that are 
faulty or present in excess. Intriguingly, under some patho-
logic conditions (for example, in some serpinopathies28) or in 
a subset of patients (for example, 10% of the ATZ patients that 
show hepatotoxicity due to intracellular accumulation of ATZ 
polymers31) or in response to severe chemically induced ER 
stresses8–10), the ER-derived material accumulates in autophago-
somes or in degradative organelles attesting defective 
clearance. In other cases, accumulation of ER fragments in 
degradative organelles occurs only on inactivation of lysosomal 
hydrolases, rather hinting at a very efficient catabolic process 
operating to protect cell and organism viability. Current models 
show that ER fragments are captured by autophagosomes 
as normally happens for cytosolic material. However, other 
mechanisms of ER delivery to degradative organelles such as 
vesicular transport can be envisioned on the basis of available 
literature33,39. It will be of great interest to study the involve-
ment of the several known autophagy genes in ER turnover 
to understand why treatment with conventional autophagy 
activators is beneficial for the clearance of cytosolic aggregates48 
and for some (for example, pro-collagen and dysferlin34–36) but 
apparently not for other (for example, ATZ and the E90K mutant 
of GnRHR)30,32,37,38 proteasome-resistant misfolded polypeptides 
generated in the ER lumen.
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